Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervarix versus Gardasil in HIV-positive young women
2013-003429-28Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in human papillomavirus infection and Cervical Cancer (CC) comparing Cervarix arm with Gardasil arm (2 arms). Primary endpoint: Occurrence and intensity of solicited local symptoms in HIV-positive subjects. Started Mar 2014; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenqHPV vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on 2013-003429-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003429-28.